{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:43:01Z","timestamp":1774352581859,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1124\/dmd.107.016402","type":"journal-article","created":{"date-parts":[[2007,7,10]],"date-time":"2007-07-10T00:39:00Z","timestamp":1184027940000},"page":"1781-1787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Interactions between Human UGT1A1, UGT1A4, and UGT1A6 Affect Their Enzymatic Activities"],"prefix":"10.1016","volume":"35","author":[{"given":"Ryoichi","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.107.016402_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0925-4439(98)00030-1","article-title":"Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease","volume":"1407","author":"Ciotti","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.107.016402_bib2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/mol.104.006361","article-title":"Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4","volume":"67","author":"Fremont","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.016402_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1124\/dmd.106.014191","article-title":"Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms","volume":"35","author":"Fujiwara","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.016402_bib4","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1046\/j.1432-1327.2001.02121.x","article-title":"Phosphorylation and oligomerization states of native pig brain HSP90 studied by mass spectrometry","volume":"268","author":"Garnier","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1124\/dmd.107.016402_bib5","doi-asserted-by":"crossref","first-page":"42108","DOI":"10.1074\/jbc.M106742200","article-title":"Homodimerization of human bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) and its functional implications","volume":"276","author":"Ghosh","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.016402_bib6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0006-2952(94)90198-8","article-title":"Radiation inactivation analysis of microsomal UDP-glucuronosyltransferases catalysing mono- and diglucuronide formation of 3,6-dihydroxybenzo(a)pyrene and 3,6-dihydroxychrysene","volume":"48","author":"Gschaidmeier","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.016402_bib7","first-page":"830","article-title":"N+-glucuronidation, a common pathway in human metabolism of drugs with a tertiary amine group","volume":"26","author":"Hawes","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.016402_bib8","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1021\/bi9702344","article-title":"Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes","volume":"36","author":"Ikushiro","year":"1997","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.107.016402_bib9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1124\/dmd.32.10.1057","article-title":"Simultaneous expression of guinea pig UDP-glucuronosyltransferase 2B21 (UGT2B21) and 2B22 in COS-7 cells enhances UGT2B21-catalyzed chloramphenicol glucuronidation","volume":"32","author":"Ishii","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.016402_bib10","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0026-895X(24)12513-8","article-title":"Simultaneous expression of guinea pig UDP-glucuronosyltransferase 2B21 and 2B22 in COS-7 cells enhances UDP-glucuronosyltransferase 2B21-catalyzed morphine-6-glucuronide formation","volume":"60","author":"Ishii","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.016402_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0006-2952(75)90240-3","article-title":"Studies on bilirubin and steroid glucuronidation by rat liver microsomes","volume":"24","author":"Jacobson","year":"1975","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.016402_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/toxsci\/61.1.49","article-title":"Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac","volume":"61","author":"King","year":"2001","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.107.016402_bib13","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1091\/mbc.e04-02-0126","article-title":"The mitochondrial message-specific mRNA protectors Cbp1 and Pet309 are associated in a high-molecular weight complex","volume":"15","author":"Krause","year":"2004","journal-title":"Mol Biol Cell"},{"key":"10.1124\/dmd.107.016402_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/dmd.31.1.133","article-title":"Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6","volume":"31","author":"Krishnaswamy","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.016402_bib15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1124\/dmd.104.002527","article-title":"Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes","volume":"33","author":"Kuehl","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.016402_bib16","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1074\/jbc.M206136200","article-title":"Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than the other UGTs and was purified as an active dimeric enzyme","volume":"278","author":"Kurkela","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.016402_bib17","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.bcp.2004.08.019","article-title":"The interactions between the N-terminal and C-terminal domains of the human UDP-glucuronosyltransferases are partly isoform-specific, and may involve both monomers","volume":"68","author":"Kurkela","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.016402_bib18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.fpc.0000173483.13689.56","article-title":"Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily","volume":"15","author":"Mackenzie","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.107.016402_bib19","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1016\/S0021-9258(18)34394-1","article-title":"Isolation and characterization of rat liver microsomal UDP-glucuronosyltransferase activity toward chenodeoxycholic acid and testosterone as a single form of enzyme","volume":"257","author":"Matern","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.016402_bib20","doi-asserted-by":"crossref","first-page":"26913","DOI":"10.1074\/jbc.272.43.26913","article-title":"UDP-glucuronosyltransferase, the role of the amino terminus in dimerization","volume":"272","author":"Meech","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.016402_bib21","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1124\/dmd.30.6.636","article-title":"Imipramine N-glucuronidation in human liver microsomes: biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms","volume":"30","author":"Nakajima","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.016402_bib22","first-page":"4821","article-title":"Oligomerization of the UDP-glucuronosyltransferase 1A proteins. Homo- and heterodimerization analysis by fluorescence resonance energy transfer (FRET) and co-immunoprecipitation","volume":"282","author":"Operana","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.016402_bib23","doi-asserted-by":"crossref","first-page":"11701","DOI":"10.1016\/S0021-9258(20)71266-4","article-title":"The molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase","volume":"259","author":"Peters","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.016402_bib24","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1172\/JCI117604","article-title":"Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase","volume":"94","author":"Seppen","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.107.016402_bib25","first-page":"121","article-title":"Evidence for significant differences in microsomal drug glucuronidation by canine and human liver and kidney","volume":"29","author":"Soars","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.016402_bib26","doi-asserted-by":"crossref","first-page":"19284","DOI":"10.1073\/pnas.0604950103","article-title":"Structure of a bacterial pyridoxal 5\u2032-phosphate synthase complex","volume":"103","author":"Strohmeier","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/dmd.107.016402_bib27","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/mol.104.007641","article-title":"Modulation of UDP-glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4","volume":"67","author":"Takeda","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.016402_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.107.016402_bib29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.105.007369","article-title":"Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) \u201cprobes\u201d for human UDP-glucuronosyltransferases","volume":"34","author":"Uchaipichat","year":"2006","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624014478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624014478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.107.016402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:05:58Z","timestamp":1739894758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624014478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0090955624014478"],"URL":"https:\/\/doi.org\/10.1124\/dmd.107.016402","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between Human UGT1A1, UGT1A4, and UGT1A6 Affect Their Enzymatic Activities","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.107.016402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}